FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107373225> ?p ?o ?g. }

• W2107373225 endingPage "1022" @default.
• W2107373225 startingPage "1022" @default.
• W2107373225 abstract "Pregabalin inhibits release of excess excitatory neurotransmitters, presumably by binding to the alpha2-delta subunit protein of widely distributed voltage-dependent calcium channels in the brain and spinal cord.To assess the anxiolytic efficacy of pregabalin in patients with generalized anxiety disorder.Double-blind, placebo-controlled, active-comparator trial. Patients were randomized to 4 weeks of treatment with pregabalin, 300 mg/d (n = 91), 450 mg/d (n = 90), or 600 mg/d (n = 89); alprazolam, 1.5 mg/d (n = 93); or placebo (n = 91).Psychiatry research and clinic settings.Outpatients meeting the DSM-IV criteria for generalized anxiety disorder, with a baseline Hamilton Anxiety Rating Scale (HAM-A) total score of 20 or greater.Change from baseline to end point in total HAM-A score in the pregabalin and alprazolam groups compared with the placebo group. The end point response criterion was 50% or greater reduction in the HAM-A total score.Pregabalin and alprazolam produced a significantly greater reduction in mean +/- SE HAM-A total score at last-observation-carried-forward end point compared with placebo (-8.4 +/- 0.8): pregabalin, 300 mg (-12.2 +/- 0.8, P<.001), 450 mg (-11.0 +/- 0.8, P = .02), and 600 mg (-11.8 +/- 0.8, P = .002), and alprazolam (-10.9 +/- 0.8, P = .02). By week 1 and at last-observation-carried-forward end point, the 3 pregabalin groups and the alprazolam group had significantly (P<.01) improved HAM-A psychic anxiety symptoms compared with the placebo group. Compared with the placebo group, HAM-A somatic anxiety symptoms were also significantly (P<.02) improved by the 300- and 600-mg pregabalin groups, but not by the 450-mg pregabalin (week 1, P = .06; week 4, P = .32) and the alprazolam groups (week 1, P = .21; week 4, P = .15). Of the 5 treatment groups, the 300-mg pregabalin group was the only medication group that differed statistically in global improvement at treatment end point not only from the placebo group but also from the alprazolam group.Pregabalin was significantly more efficacious than placebo for the treatment of psychic and somatic symptoms of generalized anxiety disorder and was well tolerated by most study patients." @default.
• W2107373225 created "2016-06-24" @default.
• W2107373225 creator A5006903600 @default.
• W2107373225 creator A5009652130 @default.
• W2107373225 creator A5015648461 @default.
• W2107373225 creator A5021268028 @default.
• W2107373225 creator A5023887700 @default.
• W2107373225 creator A5028960435 @default.
• W2107373225 creator A5065758533 @default.
• W2107373225 creator A5071755320 @default.
• W2107373225 creator A5078789680 @default.
• W2107373225 creator A5084410389 @default.
• W2107373225 date "2005-09-01" @default.
• W2107373225 modified "2023-10-17" @default.
• W2107373225 title "Pregabalin for Treatment of Generalized Anxiety Disorder" @default.
• W2107373225 cites W101037913 @default.
• W2107373225 cites W1518214111 @default.
• W2107373225 cites W154086589 @default.
• W2107373225 cites W1610432485 @default.
• W2107373225 cites W1917909847 @default.
• W2107373225 cites W1936115414 @default.
• W2107373225 cites W1967378279 @default.
• W2107373225 cites W1973948212 @default.
• W2107373225 cites W1976175860 @default.
• W2107373225 cites W1980777750 @default.
• W2107373225 cites W1990438269 @default.
• W2107373225 cites W1998935547 @default.
• W2107373225 cites W2011913908 @default.
• W2107373225 cites W2014183716 @default.
• W2107373225 cites W2016027137 @default.
• W2107373225 cites W2025707558 @default.
• W2107373225 cites W2031004040 @default.
• W2107373225 cites W2034930462 @default.
• W2107373225 cites W2049946828 @default.
• W2107373225 cites W2054260401 @default.
• W2107373225 cites W2059212626 @default.
• W2107373225 cites W2059637464 @default.
• W2107373225 cites W2068602147 @default.
• W2107373225 cites W2070246197 @default.
• W2107373225 cites W2075676284 @default.
• W2107373225 cites W2078797427 @default.
• W2107373225 cites W2090310653 @default.
• W2107373225 cites W2091470293 @default.
• W2107373225 cites W2100336567 @default.
• W2107373225 cites W2114613490 @default.
• W2107373225 cites W2115012618 @default.
• W2107373225 cites W2122450421 @default.
• W2107373225 cites W2132270420 @default.
• W2107373225 cites W2160070901 @default.
• W2107373225 cites W2160269874 @default.
• W2107373225 cites W2160500602 @default.
• W2107373225 cites W2172185379 @default.
• W2107373225 cites W2312959127 @default.
• W2107373225 cites W2460468245 @default.
• W2107373225 cites W3090293687 @default.
• W2107373225 cites W3146425672 @default.
• W2107373225 cites W47806681 @default.
• W2107373225 cites W2145938728 @default.
• W2107373225 cites W2245231029 @default.
• W2107373225 doi "https://doi.org/10.1001/archpsyc.62.9.1022" @default.
• W2107373225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16143734" @default.
• W2107373225 hasPublicationYear "2005" @default.
• W2107373225 type Work @default.
• W2107373225 sameAs 2107373225 @default.
• W2107373225 citedByCount "258" @default.
• W2107373225 countsByYear W21073732252012 @default.
• W2107373225 countsByYear W21073732252013 @default.
• W2107373225 countsByYear W21073732252014 @default.
• W2107373225 countsByYear W21073732252015 @default.
• W2107373225 countsByYear W21073732252016 @default.
• W2107373225 countsByYear W21073732252017 @default.
• W2107373225 countsByYear W21073732252018 @default.
• W2107373225 countsByYear W21073732252019 @default.
• W2107373225 countsByYear W21073732252020 @default.
• W2107373225 countsByYear W21073732252021 @default.
• W2107373225 countsByYear W21073732252022 @default.
• W2107373225 countsByYear W21073732252023 @default.
• W2107373225 crossrefType "journal-article" @default.
• W2107373225 hasAuthorship W2107373225A5006903600 @default.
• W2107373225 hasAuthorship W2107373225A5009652130 @default.
• W2107373225 hasAuthorship W2107373225A5015648461 @default.
• W2107373225 hasAuthorship W2107373225A5021268028 @default.
• W2107373225 hasAuthorship W2107373225A5023887700 @default.
• W2107373225 hasAuthorship W2107373225A5028960435 @default.
• W2107373225 hasAuthorship W2107373225A5065758533 @default.
• W2107373225 hasAuthorship W2107373225A5071755320 @default.
• W2107373225 hasAuthorship W2107373225A5078789680 @default.
• W2107373225 hasAuthorship W2107373225A5084410389 @default.
• W2107373225 hasBestOaLocation W21073732251 @default.
• W2107373225 hasConcept C118552586 @default.
• W2107373225 hasConcept C126322002 @default.
• W2107373225 hasConcept C142724271 @default.
• W2107373225 hasConcept C15744967 @default.
• W2107373225 hasConcept C204787440 @default.
• W2107373225 hasConcept C27081682 @default.
• W2107373225 hasConcept C2775858608 @default.
• W2107373225 hasConcept C2776468701 @default.
• W2107373225 hasConcept C2777196872 @default.

• next